196 related articles for article (PubMed ID: 9525632)
1. Neutralizing antibodies protect against lethal flavivirus challenge but allow for the development of active humoral immunity to a nonstructural virus protein.
Kreil TR; Maier E; Fraiss S; Eibl MM
J Virol; 1998 Apr; 72(4):3076-81. PubMed ID: 9525632
[TBL] [Abstract][Full Text] [Related]
2. Immunization with recombinant vaccinia viruses expressing structural and part of the nonstructural region of tick-borne encephalitis virus cDNA protect mice against lethal encephalitis.
Dmitriev IP; Khromykh AA; Ignatyev GM; Gainullina MN; Ageenko VA; Dryga SA; Vorobyeva MS; Sandakhchiev LS
J Biotechnol; 1996 Jan; 44(1-3):97-103. PubMed ID: 8717392
[TBL] [Abstract][Full Text] [Related]
3. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.
Pletnev AG; Bray M; Hanley KA; Speicher J; Elkins R
J Virol; 2001 Sep; 75(17):8259-67. PubMed ID: 11483771
[TBL] [Abstract][Full Text] [Related]
4. Humoral and cellular immune response to RNA immunization with flavivirus replicons derived from tick-borne encephalitis virus.
Aberle JH; Aberle SW; Kofler RM; Mandl CW
J Virol; 2005 Dec; 79(24):15107-13. PubMed ID: 16306582
[TBL] [Abstract][Full Text] [Related]
5. Vaccinia virus recombinant expressing gene of tick-borne encephalitis virus non-structural NS1 protein elicits protective activity in mice.
Khoretonenko MV; Vorovitch MF; Zakharova LG; Pashvykina GV; Ovsyannikova NV; Stephenson JR; Timofeev AV; Altstein AD; Shneider AM
Immunol Lett; 2003 Dec; 90(2-3):161-3. PubMed ID: 14687719
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity against Far Eastern and Siberian subtypes of tick-borne encephalitis (TBE) virus elicited by the currently available vaccines based on the European subtype: systematic review and meta-analysis.
Domnich A; Panatto D; Arbuzova EK; Signori A; Avio U; Gasparini R; Amicizia D
Hum Vaccin Immunother; 2014; 10(10):2819-33. PubMed ID: 25483679
[TBL] [Abstract][Full Text] [Related]
7. Stable and Highly Immunogenic MicroRNA-Targeted Single-Dose Live Attenuated Vaccine Candidate against Tick-Borne Encephalitis Constructed Using Genetic Backbone of Langat Virus.
Tsetsarkin KA; Maximova OA; Liu G; Kenney H; Teterina NL; Pletnev AG
mBio; 2019 Apr; 10(2):. PubMed ID: 31015334
[TBL] [Abstract][Full Text] [Related]
8. Vaccination against tick-borne encephalitis virus, a flavivirus, prevents disease but not infection, although viremia is undetectable.
Kreil TR; Maier E; Fraiss S; Attakpah E; Burger I; Mannhalter JW; Eibl MM
Vaccine; 1998 Jul; 16(11-12):1083-6. PubMed ID: 9682362
[TBL] [Abstract][Full Text] [Related]
9. Immunological basis for protection in a murine model of tick-borne encephalitis by a recombinant adenovirus carrying the gene encoding the NS1 non-structural protein.
Timofeev AV; Ozherelkov SV; Pronin AV; Deeva AV; Karganova GG; Elbert LB; Stephenson JR
J Gen Virol; 1998 Apr; 79 ( Pt 4)():689-95. PubMed ID: 9568962
[TBL] [Abstract][Full Text] [Related]
10. Antibodies protect mice against challenge with tick-borne encephalitis virus (TBEV)-infected macrophages.
Kreil TR; Burger I; Bachmann M; Fraiss S; Eibl MM
Clin Exp Immunol; 1997 Dec; 110(3):358-61. PubMed ID: 9409636
[TBL] [Abstract][Full Text] [Related]
11. Passive immunization reduces immunity that results from simultaneous active immunization against tick-borne encephalitis virus in a mouse model.
Kreil TR; Burger I; Attakpah E; Olas K; Eibl MM
Vaccine; 1998; 16(9-10):955-9. PubMed ID: 9682343
[TBL] [Abstract][Full Text] [Related]
12. Protective immune responses to the E and NS1 proteins of Murray Valley encephalitis virus in hybrids of flavivirus-resistant mice.
Hall RA; Brand TN; Lobigs M; Sangster MY; Howard MJ; Mackenzie JS
J Gen Virol; 1996 Jun; 77 ( Pt 6)():1287-94. PubMed ID: 8683218
[TBL] [Abstract][Full Text] [Related]
13. Protective immunity spectrum induced by immunization with a vaccine from the TBEV strain Sofjin.
Chernokhaeva LL; Rogova YV; Vorovitch MF; Romanova LIu; Kozlovskaya LI; Maikova GB; Kholodilov IS; Karganova GG
Vaccine; 2016 Apr; 34(20):2354-61. PubMed ID: 27013433
[TBL] [Abstract][Full Text] [Related]
14. Protection elicited by a replication-defective adenovirus vector expressing the tick-borne encephalitis virus non-structural glycoprotein NS1.
Jacobs SC; Stephenson JR; Wilkinson GW
J Gen Virol; 1994 Sep; 75 ( Pt 9)():2399-402. PubMed ID: 8077939
[TBL] [Abstract][Full Text] [Related]
15. Tick-borne encephalitis virus NS3 gene expression does not protect mice from homologous viral challenge.
Morozova OV; Maksimova TG; Bakhvalova VN
Viral Immunol; 1999; 12(4):277-80. PubMed ID: 10630787
[TBL] [Abstract][Full Text] [Related]
16. A synthetic peptide based on the NS1 non-structural protein of tick-borne encephalitis virus induces a protective immune response against fatal encephalitis in an experimental animal model.
Volpina OM; Volkova TD; Koroev DO; Ivanov VT; Ozherelkov SV; Khoretonenko MV; Vorovitch MF; Stephenson JR; Timofeev AV
Virus Res; 2005 Sep; 112(1-2):95-9. PubMed ID: 16022903
[TBL] [Abstract][Full Text] [Related]
17. Induction of humoral and cell-mediated immunity to the NS1 protein of TBEV with recombinant Influenza virus and MVA affords partial protection against lethal TBEV infection in mice.
Beicht J; Kubinski M; Zdora I; Puff C; Biermann J; Gerlach T; Baumgärtner W; Sutter G; Osterhaus ADME; Prajeeth CK; Rimmelzwaan GF
Front Immunol; 2023; 14():1177324. PubMed ID: 37483628
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the European tick-borne encephalitis vaccine against Omsk hemorrhagic fever virus.
Chidumayo NN; Yoshii K; Kariwa H
Microbiol Immunol; 2014 Feb; 58(2):112-8. PubMed ID: 24329534
[TBL] [Abstract][Full Text] [Related]
19. Recombinant domains III of Tick-Borne Encephalitis Virus envelope protein in combination with dextran and CpGs induce immune response and partial protectiveness against TBE virus infection in mice.
Ershova AS; Gra OA; Lyaschuk AM; Grunina TM; Tkachuk AP; Bartov MS; Savina DM; Sergienko OV; Galushkina ZM; Gudov VP; Kozlovskaya LI; Kholodilov IS; Gmyl LV; Karganova GG; Lunin VG; Karyagina AS; Gintsburg AL
BMC Infect Dis; 2016 Oct; 16(1):544. PubMed ID: 27717318
[TBL] [Abstract][Full Text] [Related]
20. [A comparison of the immune response induced by DNA or by an inactivated vaccine against tick-borne encephalitis].
Morozova OV; Popova RV; Maksimova TG; Mitrofanova EE; Bakhvalova VN
Zh Mikrobiol Epidemiol Immunobiol; 2000; (2):54-7. PubMed ID: 10808575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
